Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA delays Omeros' 2nd attempt at transplant drug’s approval
After receiving more information from the biotech, the FDA informed the company that the decision date has been pushed back to Dec. 26.
James Waldron
Aug 15, 2025 5:55am
NIH chief orders immediate research review, threatens cuts
Aug 15, 2025 3:53pm
Philips to invest $150M in US manufacturing
Aug 15, 2025 12:00pm
Pfizer vet lands first CEO role—Chutes & Ladders
Aug 15, 2025 8:30am
Fierce Pharma
HHS, NIH, CDC leaders to steer revived vaccine safety panel
Aug 14, 2025 3:52pm
Fierce Biotech Layoff Tracker 2025: Vedanta, Evotec & more
Aug 14, 2025 3:30pm
More News
Evotec's reorg claims 600 jobs, 200 more than originally planned
Aug 14, 2025 2:44pm
New Vicarious CEO pushes back surgical robot timeline
Aug 14, 2025 1:30pm
Apple Watch gets blood oxygen tracking back with software update
Aug 14, 2025 11:30am
Generative AI models build new antibiotics from scratch
Aug 14, 2025 11:00am
